Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Fuh

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology Reports|July 30, 2025
Complete response of somatic <i>POLE</i>-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapyNatasha E Charewycz, I-Chow Joe Hsu, Kevin Lu, et al.
Obstetrics and Gynecology|January 23, 2010
Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trialDeirdre J Lyell, Kristin Pullen, Katherine Fuh, et al.
Gynecologic Oncology|October 25, 2016
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trialsJohn K Chan, James J Java, Katherine Fuh, et al.
Gynecologic Oncology|September 24, 2020
Homologous recombination deficiency real-time clinical assays, ready or not?Katherine Fuh, Mary Mullen, Barbara Blachut, et al.
American Journal of Obstetrics and Gynecology|February 22, 2025
Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncologyJessica Liang, Audrey Mvemba, Megan Swanson, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transitionJessica M Devenport, Thi Tran, Brooke R Harris, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
JCI Insight|March 10, 2025
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transitionJessica M Devenport, Thi Tran, Brooke R Harris, et al.
Nanomaterials (Basel, Switzerland)|November 8, 2024
Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing MiceQingyu Zhou, John C Harding, Ping Fan, et al.
Gynecologic Oncology|April 7, 2020
FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survivalPerry W Grigsby, Leslie S Massad, David G Mutch, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology Reports|July 30, 2025
Complete response of somatic <i>POLE</i>-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapyNatasha E Charewycz, I-Chow Joe Hsu, Kevin Lu, et al.
Obstetrics and Gynecology|January 23, 2010
Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trialDeirdre J Lyell, Kristin Pullen, Katherine Fuh, et al.
Gynecologic Oncology|October 25, 2016
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trialsJohn K Chan, James J Java, Katherine Fuh, et al.
Gynecologic Oncology|September 24, 2020
Homologous recombination deficiency real-time clinical assays, ready or not?Katherine Fuh, Mary Mullen, Barbara Blachut, et al.
American Journal of Obstetrics and Gynecology|February 22, 2025
Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncologyJessica Liang, Audrey Mvemba, Megan Swanson, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transitionJessica M Devenport, Thi Tran, Brooke R Harris, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
JCI Insight|March 10, 2025
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transitionJessica M Devenport, Thi Tran, Brooke R Harris, et al.
Nanomaterials (Basel, Switzerland)|November 8, 2024
Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing MiceQingyu Zhou, John C Harding, Ping Fan, et al.
Gynecologic Oncology|April 7, 2020
FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survivalPerry W Grigsby, Leslie S Massad, David G Mutch, et al.
Pageof 3